Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001076809-26-000031
Filing Date
2026-03-19
Accepted
2026-03-19 16:46:06
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 7464
  Complete submission text file 0001076809-26-000031.txt   9362
Mailing Address 250 WEST 55TH STREET SUITE 30A NEW YORK NY 10019
Business Address 250 WEST 55TH STREET SUITE 30A NEW YORK NY 10019 212-808-7308
GLAZER CAPITAL, LLC (Filed by) CIK: 0001076809 (see all company filings)

EIN.: 134032491 | State of Incorp.: DE
Type: SCHEDULE 13G

Mailing Address 1800 SIERRA POINT PARKWAY, SUITE 200 BRISBANE CA 94005
Business Address 1800 SIERRA POINT PARKWAY, SUITE 200 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Subject) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92582 | Film No.: 26774911
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)